Longevity · Founders

Founders building longevity

Operators, clinicians, and category-defining founders shaping this beat — in their own words, and from the companies they're building.

In their own words

Conversations · 1

"The most consequential biomarkers in women's longevity are still being discovered. The category is genuinely early."

Companies

Operator network convening founders and clinical leaders.

Smart ring for health, sleep, menstrual & pregnancy tracking; ~$11B valuation.

Wearable for fitness, recovery, and metabolic-signal tracking.

TruAge™ / TruHealth™ at-home epigenetic DNA-methylation tests; 2025 NIH SBIR for W-Function Epigenomic Roadmap for women's healthspan.

Consumer longevity biotech; CheekAge™ non-invasive buccal epigenetic clock published in GeroScience (Mar 2024).

INDEX™ at-home epigenetic biological-age test (10 aging systems, developed with Dr. Morgan Levine/Yale); Basis nutraceutical (NR + pterostilbene).

$499/yr membership for 100+ blood biomarkers across 21 categories incl. hormones, longevity, metabolic; $53M Series A led by a16z.

$499/yr 'health super app' with biannual 100+ biomarker panels + AI insights; $30M Series A led by Forerunner Ventures.

Telemedicine clinic for hormone optimization & proactive longevity; 300K+ patients tested; acquired ivee in Jan 2025 with $33M Series A.